Member Login
  1. Stocks
    2. /
  2. OXB (LSE: OXB)
    3. /

LSE:OXB (OXB)

About OXB

OXB is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. OXB, a FTSE4Good constituent, is headquartered in Oxford, UK. It has bioprocessing and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France and near Boston, MA, US.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

OXB (LSE: OXB) Latest News

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

The FTSE 250 stock that doubled my money in just 6 months!

| Mark Hartley

Mark Hartley looks into the long-term prospects of a FTSE 250 medical tech stock that's returned 100% profit for me…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Up 163%, what’s going on with this FTSE 250 biotech innovator’s share price?

| Simon Watkins

This FTSE 250 biotech pioneer has soared in price since April, but Simon Watkins believes spectacular earnings growth prospects could…

Read more »

A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
Investing Articles

3 under-the-radar UK shares that could make investors richer

| Zaven Boyrazian, CFA

Motley Fool Share Advisor analyst Zaven Boyrazian outlines three hidden UK shares he’s investigating further for potential long-term returns.

Read more »

A row of satellite radars at night
Top Stocks

5 under-the-radar UK shares that deserve more attention

| The Motley Fool Staff

UK companies not widely covered may potentially offer a unique opportunity to buy shares in a future market winner.

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

This skyrocketing growth stock is up 100% this year! Is it too late to buy?

| Mark Hartley

This small-cap stock has enjoyed spectacular growth this year, so I’m examining its prospects as it transitions to its new…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

5 FTSE stocks Fools think will lead the next bull market charge

| The Motley Fool Staff

Savvy Fools will know the time to be buying the best FTSE stocks isn’t when a new bull market is…

Read more »

Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
Page

Investing in Genetics: Top UK Genetics Stocks of 2025

| Zaven Boyrazian, CFA

Explore the world of UK genetics stocks and discover the leading businesses offering explosive growth potential. Here’s what you need…

Read more »

Engineer Project Manager Talks With Scientist working on Computer with the text “Investing in Biotech: Top UK Biotech Stocks in 2022” and The Motley Fool jester cap logo
Page

Investing in Biotech: Top UK Biotech Stocks of 2025

| Zaven Boyrazian, CFA

Uncover the top UK biotech stocks & shares leading the charge in what could be a multi-trillion-dollar investment opportunity for…

Read more »

Investing Articles

1 FTSE 250 stock to buy for long-term growth

| Jabran Khan

Jabran Khan explores a FTSE 250 stock he believes is primed to grow in the long term and explains why…

Read more »

Close-up of British bank notes
Investing Articles

1 UK stock I’d buy in 2022 to try to double my money

| Zaven Boyrazian, CFA

With UK stocks on the rise in 2022, Zaven Boyrazian shares his top pick from his own portfolio that could…

Read more »

Investing Articles

The Oxford Biomedica share price is up 80% in a year. Here’s what I’d do

| Alan Oscroft

The Oxford Biomedica (LON: OXB) share price has soared more than 600% in five years. Could there be be a…

Read more »

Investing Articles

The Oxford BioMedica share price surges on earnings

| Zaven Boyrazian, CFA

The Oxford BioMedica share price is on fire this month but can the upward momentum continue? Zaven Boyrazian explores its…

Read more »